-Sabrina Robertson
Public Information Officer
Welcome to beautiful Nassau County, located in the northeast corner of Florida along the Atlantic Ocean and Interstate 95. We are proud to serve as the Eastern Gateway to the Sunshine State. From our historic island, sandy beaches, and championship golf courses to our scenic rivers, green pastures, and majestic timberlands, we truly offer something for everyone.
9/2/21 @ 10:15 a.m. - The Nassau County Department of Health has issued the attached schedule for COVID-19 Testing and Vaccines in September. If you have any questions, please call the Health Department at (904) 875-6100. -Sabrina Robertson Public Information Officer
0 Comments
8/26/21 @ 9:45 a.m. - Below is a flyer from the Nassau County Health Department regarding a current job opportunity: Road Map Strategist. If you have any questions, contact Barb Baptista at (904) 753-1258 or via email at [email protected].
-Sabrina Robertson Public Information Officer 8/24/21 @ 9:15 a.m. - The Florida Department of Health has issued the attached Press Release offering guidance on an additional mRNA COVID-19 vaccine dose at the initial two-dose vaccine series for immunocomprimised people.
If you have any questions about this release, please contact the Florida Department of Health-Nassau at (904) 875-6100. -Sabrina Robertson Public Information Officer 8/23/21 @ 1:50 p.m. - Below is a Press Release made available today on the Food & Drug Administration's website. As a reminder, vaccine locations can be located on the OneNassau website. Nassau County is also hosting After Hours Vaccination Events on Thursdays from 4:00-8:00 p.m. at the Yulee County Building located at 86026 Pages Dairy Rd., Yulee. This is for the Pfizer vaccine and is BY APPOINTMENT ONLY.
-Sabrina Robertson Public Information Officer FDA Approves First COVID-19 Vaccine Approval Signifies Key Achievement for Public Health For Immediate Release: August 23, 2021 Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. “The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.” Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product. FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA). A BLA is a comprehensive document that is submitted to the agency providing very specific requirements. For Comirnaty, the BLA builds on the extensive data and information previously submitted that supported the EUA, such as preclinical and clinical data and information, as well as details of the manufacturing process, vaccine testing results to ensure vaccine quality, and inspections of the sites where the vaccine is made. The agency conducts its own analyses of the information in the BLA to make sure the vaccine is safe and effective and meets the FDA’s standards for approval. Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into - nor does it alter - an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart. “Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness, and performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,” said Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research. “We have not lost sight that the COVID-19 public health crisis continues in the U.S. and that the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S." Source: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine 8/16/21 @ 4:15 p.m. - On August 11th, we announced that OneNassau had coordinated an after hours COVID-19 vaccination event for Wednesday, August 18th at the Yulee County Building. Please be advised that there are now two dates for after hours vaccinations: Wednesday, August 18th AND Thursday, August 19th, both from 4:00-8:00 p.m.
The vaccine being offered is Pfizer and it is available to individuals 12 and over to receive their FIRST vaccination. The date and time for your second vaccine will be provided during your scheduled appointment for the first vaccine. Please note that vaccines for these after hours events are BY APPOINTMENT ONLY. To schedule an appointment, please visit the OneNassau website. If you have any questions about these two events, please call (904) 548-0900. -Sabrina Robertson Public Information Officer 8/11/21 @ 3:40 p.m. - One Nassau has coordinated an after hours COVID-19 vaccination event for Wednesday, August 18th from 4:00-8:00 p.m. at the community building located at 86026 Pages Dairy Rd. The vaccine being offered is Pfizer and is available to individuals 12 and over to receive their FIRST vaccination. The second dose will take place 3 weeks afterwards on September 8th at the same location.
Please note that vaccines are BY APPOINTMENT ONLY. To schedule an appointment, please visit the One Nassau website. Sabrina Robertson Public Information Officer 8/10/21 @ 10:00 a.m. - Below is a chart issued by the Florida Department of Health reflecting positive Covid-19 cases through August 5, 2021. Additional Covid-19 information about Covid-19 cases in Florida can be located on the Florida Department of Health's website under the "Weekly Florida COVID-19" Data Link. You can also obtain important updates from the One Nassau website. This includes the weekly Health Department updates (like the one below), tips on protecting yourself, and monthly Covid testing schedules. The Nassau County Department of Health remains the lead agency in all Covid-19 matters. If you have any questions, please contact them at (904) 875-6100. -Sabrina Robertson Public Information Officer 8/4/21 @ 3:45 p.m. - The Florida Department of Health-Nassau will host a Back to School Vaccine Clinic on Saturday, August 7th. During this event, students can obtain any vaccine needed for school. The COVID-19 vaccine will also be available for children ages 12 and over, as well as family members, if desired. Note: No school or sports physicals will be offered. WHAT: Back to School Vaccine Clinic WHEN: Saturday, August 7th from 9:00 a.m. - 12:00 p.m. WHERE: Yulee Health Clinic, 86014 Pages Dairy Rd. Call (904) 875-6100, Option 1 if you have any questions. -Sabrina Robertson Public Information Officer 8/4/21 @ 10:00 a.m. - Below is a Health Department issued by the Florida Department of Health-Nassau. August 4th, 2021 FLORIDA DEPARTMENT OF HEALTH RECOGNIZES WORLD BREASTFEEDING WEEK Contact: Amber Lee [email protected] 904-557-9164 Tallahassee, FL.— The Florida Department of Health (DOH) and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) are celebrating World Breastfeeding Week 2021 during August 1-7, 2021. This year’s theme is Protect Breastfeeding: A Shared Responsibility. The World Breastfeeding Week 2021 theme encourages everyone to support breastfeeding mothers, babies and their families through creating a breastfeeding-friendly environment. Protecting breastfeeding ensures:
✓ Breastfeeding is readily available without needing other supplies. ✓ Breastmilk production does not require the use of energy for manufacturing and does not create waste or air pollution. To protect breastfeeding:
About the Florida Department of Health The Florida department of Health, nationally accredited by the Public Health Accreditation Board, works to protect, promote and improve the health of all people in Florida through integrated state, county and community efforts. Follow us on Twitter at @HealthyFla and on Facebook. For more information about the Florida Department of Health please visit www.FloridaHealth.gov. This institution is an equal opportunity provider. |
Archives
June 2024
Categories
All
|